Home » Archive

testnews

Syndication, testnews »

Isis Pharmaceuticals, Inc. to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Posted by sandiegobiotech May 23rd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!CARLSBAD, Calif., May 23, 2013 /PRNewswire/ — Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics…

More...

Syndication, testnews »

<b>Zensun</b> Announces Positive Clinical Results for Neucardin&#0153 to Improve Heart Function and Reduce Mortality in Chronic Heart Failure Patients

Posted by sandiegobiotech May 23rd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO and SHANGHAI, May 23, 2013 /PRNewswire/ — Zensun Sci & Tech, Ltd., a…

More...

Syndication, testnews »

Lpath, Inc. Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP

Posted by sandiegobiotech May 23rd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 23, 2013 (GLOBE NEWSWIRE) — Lpath, Inc. (Nasdaq:LPTN), the industry leader in bioactive lipid-targeted therapeutics,has initiated dosing in a Pha…

More...

Syndication, testnews »

Apricus Biosciences Prices $17.1 Million Public Offering of Common Stock and Warrants

Posted by sandiegobiotech May 23rd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 23, 2013 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq:APRI) today announced that it has priced an underw…

More...

Syndication, testnews »

Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants

Posted by sandiegobiotech May 23rd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 22, 2013 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq:APRI) today announced that it intends to offer sha…

More...

Syndication, testnews »

Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology

Posted by sandiegobiotech May 22nd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 22, 2013 /PRNewswire/ — Ambit Biosciences Corporation (Nasdaq: AMBI) today announced that data from clinical…

More...

Syndication, testnews »

Regulus Therapeutics, Inc. to Present at Deutsche Bank 38th Annual Healthcare Conference

Posted by sandiegobiotech May 22nd, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!LA JOLLA, Calif., May 21, 2013 /PRNewswire/ — Regulus Therapeutics…

More...

Syndication, testnews »

Effector Therapeutics Raises $45M to Prove New Concept in Cancer

Posted by sandiegobiotech May 21st, 2013 .
No Comments

After Switzerland’s Roche paid $230 million in cash to buy San Diego’s Anadys Pharmaceuticals in 2011, Anadys CEO Steve Worland says he felt like an entrepreneur-in-residence, but without a venture…

[[Click headline to continue reading.]]

More...

Syndication, testnews »

Ceregene, Inc. Reports Additional Efficacy Data From Parkinson’s Disease Phase 2b Study

Posted by sandiegobiotech May 21st, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 21, 2013 /PRNewswire/ — Ceregene, Inc. today announced additional efficacy data from a secondary analysis…

More...

Syndication, testnews »

New Release of Accelrys Inc. Electronic Lab Notebook Transforms Laboratory Operations

Posted by sandiegobiotech May 21st, 2013 .
No Comments

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 20, 2013 /PRNewswire/ — Accelrys, Inc. (NASDAQ…

More...